Adriano Vercellone

Salerno, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.

Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.

Journal: Epilepsia

Published: May 20, 2025

Profile, Healthcare Resource Consumption and Related Costs in ANCA-Associated Vasculitis Patients: A Real-World Analysis in Italy.

Profile, Healthcare Resource Consumption and Related Costs in ANCA-Associated Vasculitis Patients: A Real-World Analysis in Italy.

Journal: Advances in therapy

Published: June 30, 2023

Hepatitis C Virus Micro-Elimination Plan in Southern Italy: The "HCV ICEberg" Project.

Hepatitis C Virus Micro-Elimination Plan in Southern Italy: The "HCV ICEberg" Project.

Journal: Pathogens (Basel, Switzerland)

Published: December 31, 2022

Exploring Contemporary Data on Lipid-Lowering Therapy Prescribing in Patients Following Discharge for Atherosclerotic Cardiovascular Disease in the South of Italy.

Exploring Contemporary Data on Lipid-Lowering Therapy Prescribing in Patients Following Discharge for Atherosclerotic Cardiovascular Disease in the South of Italy.

Journal: Journal of clinical medicine

Published: July 06, 2022

Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting.

Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting.

Journal: Healthcare (Basel, Switzerland)

Published: February 22, 2022

Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources.

Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: February 09, 2022

The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes.

The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: March 30, 2021

Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia.

Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia.

Journal: Therapeutics and clinical risk management

Published: March 05, 2021

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.

Journal: PloS one

Published: March 29, 2019

Impact Laws And Decrees On Activities: The Ilda Study.

Impact Laws And Decrees On Activities: The Ilda Study.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 01, 2014

Nilotinib for the Frontline Treatment of Chronic Myeloid Leukemia Carrying the p230 Transcript: Dream or Reality?

Nilotinib for the Frontline Treatment of Chronic Myeloid Leukemia Carrying the p230 Transcript: Dream or Reality?

Journal: Frontiers in oncology

Published: September 26, 2013

Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization.

Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization.

Journal: Frontiers in pharmacology

Published: July 29, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026